UNSPSC 51161726: Dimefline hydrochloride

This classification denotes a cns stimulant with the molecular formula C20H21NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H0XB4R74ID, chemically known as 4h-1-benzopyran-4-one, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-2-phenyl- (9ci) but more generally known as dimefline hydrochloride, which bears US NIH Compound Identifier 3078. European Medicines Agency schedules Dimefline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01738MIG.

UNSPSC 51161726 Dimefline hydrochloride is a Commodity code, but the recent state and local contract opportunities posted under this code show minimal relevant activity. The code nominally names a specific pharmaceutical ingredient, yet the recent opportunities tagged to it involve naloxone procurement, on-site pharmacy services contracting, direct-to-manufacturer prescription program planning, and multi-source generic pharmaceutical and OTC product supply agreements — none of which involve dimefline hydrochloride specifically. The mismatch suggests either systematic miscoding of pharmaceutical opportunities within the state and local procurement ecosystem or that this Commodity code does not reflect the actual purchasing patterns of state and local health agencies.

The four opportunities posted between January and June 2026 span three states and represent health system procurement by a county health department (Seminole County, Florida), a county government benefits function (Hall County, Georgia), a state health agency (Texas HHS Commission), and a multi-state cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance serving state and local governments including Oregon). None of the solicitations — an IFB for naloxone and drug deactivation systems, an RFQ/P for on-site pharmacy services, an RFI for direct manufacturer prescription programs, and an RFP for generic multi-source pharmaceuticals — target dimefline hydrochloride as a line item or named product. Business development professionals evaluating this code should treat it as effectively inactive for dimefline-specific procurement and monitor whether state and local health purchasing offices continue to apply this Commodity code to broader pharmaceutical and pharmacy contracting work or correct their coding practices going forward.